Christopher McCann was awarded the 2014 KickStart first prize for snap40 - who catch deteriorating health sooner by automatically identifying the warning signs, providing targeted early alerts to allow physicians to intervene earlier.
After completing a Master’s in Computer Science from the University of Strathclyde, Christopher then studied medicine at the University of Dundee. After taking part in day-to-day practice, he identified a key problem with the monitoring of patients whose health had deteriorated because warning signs were not detected at an early enough stage. Christopher made the decision to take a leave of absence to focus on snap40.
snap40 transmits 15,000 data points every 30 seconds from their wearable arm-band and then use advanced algorithmic analysis to allow health services to easily and quickly identify high and low risk patients in hospital. Doctors and nurses can intervene earlier in high risk patients, allowing them to leave hospital earlier and improve patient outcomes.
“Converge Challenge provided snap40 with access to much needed pre-seed capital as well as introductions to a strong and varied network of other entrepreneurs and scientists.”
snap40 has secured funding from Scottish Institute of Enterprise (SIE), Scottish Enterprise and Scottish EDGE, and has pitched at Engage Invest Exploit (EIE).
In 2017, snap40 were awarded a £1 million SBRI healthcare development contract by NHS England to further scale their technology and provide critical validation funding for clinical studies with NHS Fife and with NHS Lothian’s Emergency Medicine Research Group Edinburgh (EMERGE).
In July 2018, snap40 raised $8 million in seed funding - the largest funding round by a UK digital healthcare business - bringing the total seed fund raised by the company to $10 million.
Their wearable device is being exhibited in the V&A Dundee - Scotland's first design museum.